Company: INVUP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001493152-25-011912
Chunk: 122

Company: Investview, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 122
---
     8,823 
  
    Total 
     1,216,437 

    Goodwill 
    $873,701 

    [1]
    Domain
    names were deemed to have an indefinite life; therefore, amounts are not amortized, but rather are assessed for impairment as further
    discussed in our impairment policy.

    [2]
    This
    amount is equal to the $1,780,000 purchase price less $572,386 of customer deposits collected by Renu Labs, Inc. prior to acquisition.

    31

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2025

(Unaudited)

NOTE
14 – INCOME TAXES

For
the periods ended June 30, 2025, and June 30, 2024, the Company used a discrete effective tax rate method for recording income taxes,
as compared to an estimated full year annual effective tax rate method, as an estimate of the annual effective tax rate cannot be made.

Provision
for Income taxes for the three and six months ended June 30, 2025 was $1,000 and $11,000, respectively, resulting in an effective tax
rate of 0.2% and (4.4%), respectively. Provision for Income taxes for the three and six months ended June 30, 2024 was $269,067 and $769,142,
respectively, resulting in an effective tax rate of 33.6% and 25.9%, respectively. The provision for income taxes was primarily impacted
by pretax book income, permanent differences, and by the change in valuation allowance on deferred tax assets.

NOTE
15 – SUBSEQUENT EVENTS

In
accordance with ASC Topic 855, Subsequent Events, we have evaluated subsequent events through the date of this filing and have determined
that the following events require disclosure.

During
the period subsequent to period end, according to the stock repurchase program (see NOTE 10), the Company bought back 2,578,934 shares
of their own common stock for $34,446. These shares are being held by the Company in Treasury.

On
July 4, 2025, the U.S. government enacted The One Big Beautiful Bill Act (“OBBBA”). This bill includes various provisions,
among them including the allowance of immediate expensing of qualifying research and development expenses and extensions